Leuprorelin

Amber-G

Brand Name(s):Prostap SR DCS, Prostap 3 DCS

Indication:Cancer – Prostate locally advanced and metastatic

Rationale:

Considered:May-08

Review Date:Sep-22

Comments:
NICE CG175
Prostate cancer:diagnosis & treatment:http://www.nice.org.uk/nicemedia/live/14348/66226/66226.pdf
Jan 2014
…………………………
For full guidance and monitoring requirements please refer to the “Guidance for the Prescribing of Goserelin, Leuprorelin & Triptorelin in the treatment of Prostate Cancer” paper which can be found in the Guidelines (Local) section of the NHS Doncaster Medicines Management Website